LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$99.97
-0.27 (-0.27%)
▼
5d:
-0.97%
30d:
-3.62%
90d:
+5.82%
BUY
HIGH Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LNTH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: LNTH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$129.70
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$80.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $99.97, which is considered slightly low relative to its 30-day fair value range of $100.08 to $105.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.8) compared to its historical average (13.7). At these levels, the market is pricing in 4.8% annual earnings growth.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is currently testing key support at $99.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNTH scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is currently testing key support at $99.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNTH scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$100.08 -
$105.00
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (73/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($107.04)
- BULLISH: Expecting earnings turnaround to 4.8% growth with 2.7% revenue growth
- BULLISH: Bottoming setup score 73/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$100.08 -
$105.00
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$99.97
Resistance Level
$101.10
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.81
Wall Street Target
$107.04
(+7.1%)
Revenue Growth (YoY)
2.7%
Earnings Growth (YoY)
-0.9%
Profit Margin
17.7%
Valuation Premium vs History
+4.8% premium
PE vs Historical
15.8 vs 13.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.8%
(market-implied from PE analysis)
1-Year Target
$104.77
(+5%)
2-Year Target
$109.80
(+10%)
3-Year Target
$115.07
(+15%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$99.72
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 12.9%)
$182.78
(+83%)
Base:
(SPY PE: 15.8, Growth: 12.9%)
$143.97
(+44%)
Bear:
(PE: 13.4, Growth: 12.9%)
$122.37
(+22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 24.04 | Current EPS (TTM): $4.17
Bull Case
$167.22
(+67%)
Analyst growth 51.7%, PE expands to 26.4
Base Case
$152.02
(+52%)
Market implied 51.7%, PE stable at 24.0
Bear Case
$68.16
(-32%)
Severe decline -20.0%, PE contracts to 20.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$653 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 42 HOLD |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
